Table 1.
Discovery |
Identifying the contribution of genetic variants to drug outcomes |
Establishing interactions among genes and between genes and the environment |
Translation |
Establishing which genetic variants should be used in which settings |
Implementation |
Education |
Patients |
Healthcare providers |
Genotyping |
At the point of care or preemptively |
Assay quality |
Decision support |
Developing rules |
Deploying advice in an electronic medical record environment |
Analyzing outcomes |
Population and individual health |
Balancing costs and benefits |